Stellaromics, a pioneer in 3D spatial biology spun out of the laboratories of Karl Deisseroth (Stanford University) and Xiao Wang (MIT and Broad Institute), today announced the completion of a Series B funding round in the amount of $80M. The round, led by Catalyst4 with participation from Stanford University Ventures, will support the development and commercialization of Pyxa, Stellaromics' groundbreaking 3D spatial biology platform..

Stellaromics是3D空间生物学的先驱，由Karl Deisseroth（斯坦福大学）和Xiao Wang（麻省理工学院和布罗德研究所）的实验室组成，今天宣布完成金额为8000万美元的B轮融资。这一轮由Catalyst4牵头，斯坦福大学风险投资公司（Stanford University Ventures）参与，将支持Stellaromics开创性的3D空间生物学平台Pyxa的开发和商业化。。

Stellaromics is a privately held company dedicated to pioneering breakthroughs in 3D spatial multi-omics. The company's mission is to empower researchers with cutting-edge tools that illuminate the complexities of biological systems, enabling groundbreaking discoveries that improve human health.

Stellaromics是一家私营公司，致力于3D空间多组学的开创性突破。该公司的使命是为研究人员提供尖端工具，以阐明生物系统的复杂性，从而实现改善人类健康的突破性发现。